» Articles » PMID: 27127594

The Prevalence of Hepatitis B and C Among Prisoners in Kahramanmaras, Turkey

Overview
Publisher Brieflands
Specialty Microbiology
Date 2016 Apr 30
PMID 27127594
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are among the most important health issues in Turkey. Human immunodeficiency virus (HIV) infections are less frequently observed in the country. The individuals who had blood transfusions, patients undergoing hemodialysis, and intravenous drug addicted individuals, people who had tattoos/piercings, communal living environments, contamination of a family member, and prisoners are the main risk groups.

Objectives: The current study aimed to discuss the prevalence and the genotypes of hepatitis and HIV infections among a specific group, namely individuals incarcerated in prisons.

Patients And Methods: Two-hundred and sixty-six prisoners sentenced for crimes such as robbery, sexual assault, assault substance abuse or selling drugs in the Kahramanmaras closed prison were recruited for the study. Demographic data and the presence of hepatitis B, hepatitis C and HIV were investigated in the study subjects.

Results: Out of the 266 cases included in the study, 89.5% were male, 10.5% were female and the mean age was 31.21 ± 8.99 years. Risk factors were detected in 27.4% of the subjects. Out of the 73 subjects, among whom the risk factors were detected, 20.3% had intravenous substance use, 3.8% had a history of operation/transfusion, 1.9% had a history of indentation and 1.5% had unprotected sexual contact. The rate of hepatitis B surface antigen (HBsAg) positivity was 2.6%, the ratio of anti-HBs positive subjects was 35.0% and immunity was achieved with vaccination in 43% of the subjects. Anti-HCV was positive in 17.7% of the prisoners and the genotype 3 and genotype 1 were 68.1% (n = 32) and 2.1% (n = 1), respectively.

Conclusions: Continued substance abuse among most of the drug addicted individuals in prisons, common use of injection materials, tattoos and other circumstances that cause blood contact increase the risk of blood-borne infections.

Citing Articles

Viral Hepatitis B and C Prevalence and Related Risk Factors Among Prisons in Duhok City, Kurdistan Region, Iraq.

Abdulrahman M, Shahab F, Khaleel B, Abdullah I, Abdulkarim N Cureus. 2024; 16(11):e73153.

PMID: 39512803 PMC: 11540890. DOI: 10.7759/cureus.73153.


Hepatitis B and hepatitis C virus infections and associated factors among prisoners in Gondar City, Northwest Ethiopia.

Tadesse K, Ayalew G, Million Y, Gelaw A PLoS One. 2024; 19(4):e0301973.

PMID: 38626232 PMC: 11020974. DOI: 10.1371/journal.pone.0301973.


Modeling the Health Economic Burden of Hepatitis C Virus Infection in Turkey: Cost-Effectiveness of Targeted Screening.

Cekin A, Guner R, Inkaya A, Oguz D, Ozdemir O, Tabak O Turk J Gastroenterol. 2023; 34(10):1062-1070.

PMID: 37565793 PMC: 10645295. DOI: 10.5152/tjg.2023.22749.


Hepatitis C prevalence in incarcerated settings between 2013-2021: a systematic review and meta-analysis.

Busschots D, Kremer C, Bielen R, Koc O, Heyens L, Nevens F BMC Public Health. 2022; 22(1):2159.

PMID: 36419013 PMC: 9685883. DOI: 10.1186/s12889-022-14623-6.


Global prevalence of hepatitis C in prisoners: a comprehensive systematic review and meta-analysis.

Salari N, Darvishi N, Hemmati M, Shohaimi S, Ghyasi Y, Hossaini F Arch Virol. 2022; 167(4):1025-1039.

PMID: 35165781 DOI: 10.1007/s00705-022-05382-1.


References
1.
Mohammad Alizadeh A, Alavian S, Jafari K, Yazdi N . Prevalence of hepatitis C virus infection and its related risk factors in drug abuser prisoners in Hamedan--Iran. World J Gastroenterol. 2005; 11(26):4085-9. PMC: 4502106. DOI: 10.3748/wjg.v11.i26.4085. View

2.
Nelson P, Mathers B, Cowie B, Hagan H, Des Jarlais D, Horyniak D . Global epidemiology of hepatitis B and hepatitis C in people who inject drugs: results of systematic reviews. Lancet. 2011; 378(9791):571-83. PMC: 3285467. DOI: 10.1016/S0140-6736(11)61097-0. View

3.
Pollini R, Alvelais J, Gallardo M, Vera A, Lozada R, Magis-Rodriquez C . The harm inside: injection during incarceration among male injection drug users in Tijuana, Mexico. Drug Alcohol Depend. 2009; 103(1-2):52-8. PMC: 2693031. DOI: 10.1016/j.drugalcdep.2009.03.005. View

4.
Okie S . Sex, drugs, prisons, and HIV. N Engl J Med. 2007; 356(2):105-8. DOI: 10.1056/NEJMp068277. View

5.
Messina J, Humphreys I, Flaxman A, Brown A, Cooke G, Pybus O . Global distribution and prevalence of hepatitis C virus genotypes. Hepatology. 2014; 61(1):77-87. PMC: 4303918. DOI: 10.1002/hep.27259. View